Cabot Corporation filings document the public reporting of a NYSE-listed specialty chemicals and performance materials company with common stock trading under CBT. Its 8-K filings furnish quarterly operating results and segment disclosures for Reinforcement Materials and Performance Chemicals, including revenue, EPS, segment EBIT, dividend actions, product-line trends and capital allocation items.
Cabot’s proxy and annual meeting filings cover board structure, director elections, advisory executive compensation votes, auditor ratification and related governance matters. Other current reports record board-class adjustments and Exchange Act disclosures tied to the company’s registered common stock and corporate governance framework.
Cabot Corporation entered into a new $1.3 billion unsecured revolving credit agreement with a syndicate of banks arranged by JPMorgan entities. The multi-currency facility is for general corporate purposes and matures on May 12, 2031, extending the company’s access to committed liquidity.
Loans will bear interest at a Term Benchmark or RFR Spread rate plus a margin between 0.68% and 1.20%, depending on Cabot’s credit ratings. The agreement includes a quarterly leverage test, requiring net debt not to exceed 3.75x consolidated EBITDA, rising to 4.25x for a limited period following any material acquisition.
At the same time, Cabot terminated its prior $1 billion revolving credit agreement and separate €300 million revolving credit agreement, both of which had been scheduled to mature on August 6, 2027. The new facility consolidates these arrangements under a single, larger long-term credit line.
Cabot Corporation reported lower results for the quarter ended March 31, 2026. Net sales were $904 million versus $936 million a year earlier, and net income attributable to Cabot fell to $68 million, or $1.27 per diluted share, from $94 million, or $1.69.
Performance was pressured by weaker pricing and product mix in the Reinforcement Materials segment, partly offset by higher earnings in Performance Chemicals and initial contribution from the $68 million MXCB acquisition in Mexico. Cabot also initiated and approved restructuring actions, including plant closures in Europe and Argentina, with expected pre-tax charges of about $79 million and future cash outlays of $24 million.
Cabot Corporation reported softer second-quarter fiscal 2026 results, but reaffirmed its full-year outlook. For the quarter ended March 31, 2026, net sales were $904 million versus $936 million a year earlier. Net income attributable to Cabot was $68 million, down from $94 million, and diluted EPS declined to $1.27 from $1.69. Adjusted EPS was $1.61, compared with $1.90 in the prior-year quarter.
Reinforcement Materials segment EBIT fell to $93 million from $131 million, as lower pricing and product mix more than offset a 3% volume increase. Performance Chemicals segment EBIT rose to $59 million from $50 million, helped by better product mix and higher volumes in battery materials and specialty carbons.
Cabot raised its quarterly dividend by 5%, increasing the annualized rate from $1.80 to $1.89 per share, and plans to close certain manufacturing operations in South America and Europe, targeting about $22 million in annualized fixed cost savings once fully implemented. The company reported available liquidity of $1.3 billion and a net debt to EBITDA ratio of 1.5x as of March 31, 2026, and reaffirmed full-year Adjusted EPS guidance of $6.00–$6.50 per share.
Vanguard Capital Management reported beneficial ownership of 2,727,381 shares of Cabot Corp Common Stock, representing 5.22% of the class as reported on this Schedule 13G. The filer indicates sole voting power over 403,074 shares and sole dispositive power over 2,727,381 shares. The filing states these holdings include securities held for Vanguard funds and managed accounts. The signature date on the filing is 04/29/2026.
Vanguard Portfolio Management reports beneficial ownership of 3,175,315 shares of Cabot Corp common stock, equal to 6.08% of the class as of 03/31/2026. The filing shows Vanguard has sole dispositive power over 3,175,315 shares and sole voting power for 53,973 shares. The disclosure is submitted on a Schedule 13G and signed on 04/29/2026.
Nathoo Raffiq reported acquisition or exercise transactions in this Form 4 filing.
Cabot Corp director Raffiq Nathoo received a grant of 315.3632 Phantom Stock Units on March 31, 2026 as compensation. Each unit is tied 1-for-1 to Cabot common stock and was valued at $75.31 per unit for this award.
These Phantom Stock Units are settled in cash, not shares, and will be paid either when Nathoo’s board service ends or according to his distribution election, whichever happens first. After this grant, he holds a total of 1,607.7435 Phantom Stock Units, reflecting deferred, cash-settled exposure to Cabot’s share value rather than an open-market stock purchase or sale.
Cabot Corp: The Vanguard Group filed an amendment to its Schedule 13G to report 0 shares of Cabot Corp common stock, representing 0% of the class as disclosed in the amendment. The filing explains an internal realignment effective January 12, 2026, under SEC Release No. 34-39538, which caused certain Vanguard subsidiaries and business divisions to report beneficial ownership separately.
Cabot Corp VP, Controller & CAO Lisa M. Dumont received an automatic grant of 4.7528 phantom stock units on March 13, 2026. These units represent dividends paid on previously acquired phantom stock under Cabot’s Supplemental 401(k) Plan and are credited on a 1-for-1 basis with common shares. After this grant, Dumont holds a total of 738.6704 phantom stock units, which will be settled in connection with her retirement or other termination of employment.
Cabot Corp Executive Vice President and CFO Erica McLaughlin received a grant of 65.9221 phantom stock units on common stock, valued at $69.49 per unit. This increased her phantom stock balance to 10,245.7476 units.
According to the footnotes, these units represent dividends paid on previously acquired phantom stock units under Cabot’s Supplemental 401(k) Plan. The phantom stock units are credited on a 1-for-1 basis with Cabot common stock and are scheduled to be settled in shares after her retirement or other termination of employment, rather than being immediately tradable stock.
DELGROSSO DOUGLAS G reported acquisition or exercise transactions in this Form 4 filing.
CABOT CORP director Douglas G. DelGrosso received an additional 33.0535 phantom stock units credited on March 13, 2026. These units were valued at $69.4900 per unit and increase his deferred phantom stock balance to 5,137.2601 units.
The footnotes explain that the units represent dividends paid on phantom stock units under the Corporation's Non-Employee Director's Deferral Plan. They will be settled on a 1-for-1 basis in Cabot common stock either when he leaves the board or according to his chosen distribution schedule, whichever happens first.